Amed Co., Ltd. (UNQ: 7575)
Health Care · Health Care Equipment & Supplies · TW
NT$—
— today · — 1Y
Amed Co., Ltd. (UNQ: 7575) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $10.17M and employs 175 people.
trading between 8.16 and 32.60.
7575 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.17M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$32.60
- 52-week low
- NT$8.16
- Avg volume (3M)
- —
- Shares outstanding
- 30.00M
- Employees
- 175
- Next earnings
- —
About Amed Co., Ltd.
Amed Co., Ltd., based in New Taipei City, Taiwan, operates as a developer, manufacturer, and distributor of medical equipment within the region. Established in 2008, the company offers a diverse portfolio of products. Its wound care segment features HERADERM-branded dressing products, along with Genadyne negative pressure wound therapy systems specifically engineered to deliver continuous 24-hour oxygen to wounds, and Natrox wound treatment systems. Beyond wound care, Amed's offerings also include Naldebain, a line of injections providing extended pain relief for up to seven days. Furthermore, the company provides POLYSITE pressure injectable implantable port kits and easyEndo universal linear cutting staplers.
- ISIN
- TW0007575B17
- Founded
- 2008
- Listed since
- Jun 28, 2022
- Exchange
- Unquoted Security
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.